iron bisglycinate high dose
Selected indexed studies
- Low-dose ferrous bisglycinate chelate supplementation in chronic kidney disease and hemodialysis patients. (J Chin Med Assoc, 2022) [PMID:35358119]
- Assessment of the Efficacy of a Low-Dose Iron Supplement in Restoring Iron Levels to Normal Range among Healthy Premenopausal Women with Iron Deficiency without Anemia. (Nutrients, 2023) [PMID:37299583]
- Improvement of in vivo iron bioavailability using mung bean peptide-ferrous chelate. (Food Res Int, 2024) [PMID:38945571]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Addition of oral iron bisglycinate to intravenous iron sucrose for the treatment of postpartum anemia-randomized controlled trial. (2021) pubmed
- Assessment of the Efficacy of a Low-Dose Iron Supplement in Restoring Iron Levels to Normal Range among Healthy Premenopausal Women with Iron Deficiency without Anemia. (2023) pubmed
- Low-dose ferrous bisglycinate chelate supplementation in chronic kidney disease and hemodialysis patients. (2022) pubmed
- Improvement of in vivo iron bioavailability using mung bean peptide-ferrous chelate. (2024) pubmed
- Toxicology and safety of Ferrochel and other iron amino acid chelates. (2001) pubmed
- Effectiveness of treatment of iron-deficiency anemia in infants and young children with ferrous bis-glycinate chelate. (2001) pubmed
- Efficacy of ferrous bis-glycinate versus ferrous glycine sulfate in the treatment of iron deficiency anemia with pregnancy: a randomized double-blind clinical trial. (2019) pubmed